NVQ

Bacteriophage And Controls, B. Anthracis Lysis

Product code
NVQ
Device name
Bacteriophage And Controls, B. Anthracis Lysis
Device class
Class 2
21 CFR
21 CFR 866.3045
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (all years, FDA)
2 (all years; only the last 3 years are listed here)

FDA classification definition

A gamma phage lysis assay intended for the identification of bacillus anthracis from non-hemolytic, aerobic gram positive colonies isolated from sheep blood agar. To aid in the laboratory identification of bacillus anthracis culture growth by lysis with a specific bacteriophage.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: NVQ
Classification and pathway per current FDA publications. Data from openFDA (CC0).